Literature DB >> 19323967

Mild behavioral impairment and risk of dementia: a prospective cohort study of 358 patients.

Fernando E Taragano1, Ricardo F Allegri, Hugo Krupitzki, Diego R Sarasola, Cecilia M Serrano, Leandro Loñ, Constantine G Lyketsos.   

Abstract

BACKGROUND: Mild cognitive impairment (MCI) is a transitional state between normal aging and dementia, at least for some patients. Behavioral symptoms in MCI are associated with a higher risk of dementia, but their association with dementia risk in patients without MCI is unknown. Mild behavioral impairment (MBI) refers to a late-life syndrome with prominent psychiatric and related behavioral symptoms in the absence of prominent cognitive symptoms that may also be a dementia prodrome. This study sought to compare MCI and MBI patients and to estimate the risk of dementia development in these 2 groups.
METHOD: Between January 2001 and January 2006, a consecutive series of 358 elderly (>or= 65 years old) patients (239 with MCI and 119 with MBI) presenting to an outpatient general hospital specialty clinic were followed for up to 5 years until conversion to dementia or censoring.
RESULTS: Thirty-four percent of MCI patients and over 70% of patients with MBI developed dementia (log-rank p = .011). MBI patients without cognitive symptoms were more likely to develop dementia (log-rank p < .001). MBI patients were more likely to develop frontotemporal dementia (FTD) than dementia of the Alzheimer's type (DAT).
CONCLUSION: MBI appears to be a transitional state between normal aging and dementia. MBI (specifically in those without cognitive symptoms) may confer a higher risk for dementia than MCI, and it is very likely an FTD prodrome in many cases. These findings have implications for the early detection, prevention, and treatment of patients with dementia in late life, by focusing the attention of researchers on the emergence of new behavioral symptoms. ©Copyright 2009 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19323967      PMCID: PMC2711522          DOI: 10.4088/jcp.08m04181

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  30 in total

Review 1.  Mild cognitive impairment.

Authors:  Serge Gauthier; Barry Reisberg; Michael Zaudig; Ronald C Petersen; Karen Ritchie; Karl Broich; Sylvie Belleville; Henry Brodaty; David Bennett; Howard Chertkow; Jeffrey L Cummings; Mony de Leon; Howard Feldman; Mary Ganguli; Harald Hampel; Philip Scheltens; Mary C Tierney; Peter Whitehouse; Bengt Winblad
Journal:  Lancet       Date:  2006-04-15       Impact factor: 79.321

2.  An inventory for measuring depression.

Authors:  A T BECK; C H WARD; M MENDELSON; J MOCK; J ERBAUGH
Journal:  Arch Gen Psychiatry       Date:  1961-06

3.  Economic impact of dementia in developing countries: an evaluation of costs of Alzheimer-type dementia in Argentina.

Authors:  Ricardo F Allegri; Judith Butman; Raúl L Arizaga; Gerardo Machnicki; Cecilia Serrano; Fernando E Taragano; Diego Sarasola; Leandro Lon
Journal:  Int Psychogeriatr       Date:  2006-07-27       Impact factor: 3.878

4.  Mild behavioral impairment: a prodromal stage of frontotemporal lobar degeneration.

Authors:  Carla J M Schölzel-Dorenbos
Journal:  J Am Geriatr Soc       Date:  2006-01       Impact factor: 5.562

Review 5.  Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria.

Authors:  D Neary; J S Snowden; L Gustafson; U Passant; D Stuss; S Black; M Freedman; A Kertesz; P H Robert; M Albert; K Boone; B L Miller; J Cummings; D F Benson
Journal:  Neurology       Date:  1998-12       Impact factor: 9.910

6.  Primitive reflex evaluation in the clinical assessment of extrapyramidal syndromes.

Authors:  B Borroni; M Broli; C Costanzi; S Gipponi; N Gilberti; C Agosti; A Padovani
Journal:  Eur J Neurol       Date:  2006-09       Impact factor: 6.089

7.  Depression, apolipoprotein E genotype, and the incidence of mild cognitive impairment: a prospective cohort study.

Authors:  Yonas E Geda; David S Knopman; David A Mrazek; Gregory A Jicha; Glenn E Smith; Selamawit Negash; Bradley F Boeve; Robert J Ivnik; Ronald C Petersen; V Shane Pankratz; Walter A Rocca
Journal:  Arch Neurol       Date:  2006-03

8.  Prevalence of primitive reflexes and the relationship with cognitive change in healthy adults: a report from the Maastricht Aging Study.

Authors:  M P J van Boxtel; H Bosma; J Jolles; F W Vreeling
Journal:  J Neurol       Date:  2006-03-06       Impact factor: 4.849

Review 9.  [Epidemiology of Alzheimer disease and related disorders].

Authors:  Catherine Helmer; Florence Pasquier; Jean-François Dartigues
Journal:  Med Sci (Paris)       Date:  2006-03       Impact factor: 0.818

10.  Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study.

Authors:  Martin Steinberg; Huibo Shao; Peter Zandi; Constantine G Lyketsos; Kathleen A Welsh-Bohmer; Maria C Norton; John C S Breitner; David C Steffens; Joann T Tschanz
Journal:  Int J Geriatr Psychiatry       Date:  2008-02       Impact factor: 3.485

View more
  53 in total

1.  Prevalence of neuropsychiatric symptoms in CIND and its subtypes: the Cache County Study.

Authors:  Matthew E Peters; Paul B Rosenberg; Martin Steinberg; JoAnn T Tschanz; Maria C Norton; Kathleen A Welsh-Bohmer; Kathleen M Hayden; John C S Breitner; Constantine G Lyketsos
Journal:  Am J Geriatr Psychiatry       Date:  2012-05       Impact factor: 4.105

2.  Frontotemporal Dementia and Psychiatric Illness: Emerging Clinical and Biological Links in Gene Carriers.

Authors:  Nikolas R Block; Sharon J Sha; Anna M Karydas; Jamie C Fong; Mary G De May; Bruce L Miller; Howard J Rosen
Journal:  Am J Geriatr Psychiatry       Date:  2015-06-21       Impact factor: 4.105

3.  Latent Classes of Neuropsychiatric Symptoms in NACC Controls and Conversion to Mild Cognitive Impairment or Dementia.

Authors:  Jeannie-Marie S Leoutsakos; Sarah N Forrester; Constantine G Lyketsos; Gwenn S Smith
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

4.  Simulating effects of biomarker enrichment on Alzheimer's disease prevention trials: conceptual framework and example.

Authors:  Jeannie-Marie S Leoutsakos; Alexandra L Bartlett; Sarah N Forrester; Constantine G Lyketsos
Journal:  Alzheimers Dement       Date:  2013-08-15       Impact factor: 21.566

5.  Neuropsychiatric symptoms in Alzheimer's disease.

Authors:  Constantine G Lyketsos; Maria C Carrillo; J Michael Ryan; Ara S Khachaturian; Paula Trzepacz; Joan Amatniek; Jesse Cedarbaum; Robert Brashear; David S Miller
Journal:  Alzheimers Dement       Date:  2011-09       Impact factor: 21.566

6.  Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment.

Authors:  Zahinoor Ismail; Eric E Smith; Yonas Geda; David Sultzer; Henry Brodaty; Gwenn Smith; Luis Agüera-Ortiz; Rob Sweet; David Miller; Constantine G Lyketsos
Journal:  Alzheimers Dement       Date:  2015-06-18       Impact factor: 21.566

7.  The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease.

Authors:  Paul B Rosenberg; Michelle M Mielke; Brian S Appleby; Esther S Oh; Yonas E Geda; Constantine G Lyketsos
Journal:  Am J Geriatr Psychiatry       Date:  2013-02-06       Impact factor: 4.105

Review 8.  Non-cognitive symptoms and related conditions in the Alzheimer's disease: a literature review.

Authors:  Francesco Raudino
Journal:  Neurol Sci       Date:  2013-03-31       Impact factor: 3.307

9.  Mapping brain morphological and functional conversion patterns in predementia late-onset bvFTD.

Authors:  Silvia Morbelli; Michela Ferrara; Francesco Fiz; Barbara Dessi; Dario Arnaldi; Agnese Picco; Irene Bossert; Ambra Buschiazzo; Jennifer Accardo; Lorena Picori; Nicola Girtler; Paola Mandich; Marco Pagani; Gianmario Sambuceti; Flavio Nobili
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-03-01       Impact factor: 9.236

Review 10.  Neuropsychiatric Symptoms in Mild Cognitive Impairment.

Authors:  Damien Gallagher; Corinne E Fischer; Andrea Iaboni
Journal:  Can J Psychiatry       Date:  2017-03       Impact factor: 4.356

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.